Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade

Journal:

Cell

Published:

2026-04-17

DOI:

10.1016/j.cell.2026.03.041

Affiliations:

7

Authors:

8

Go to article

Institutions	Authors	Share
NYU Langone Health, United States of America (USA)	2.916667	0.36
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA)	2.583333	0.32
Department of Pediatrics, UC San Diego, United States of America (USA)	2.000000	0.25
Albert Einstein College of Medicine (Einstein), United States of America (USA)	0.500000	0.06

Interested in Clinical Sciences?